Innovative Therapies for Children with Cancer in Europe

BDA Workshop

BDA Workshop

BDA workshop Minimal residual disease and pathological complete response: endpoints ... | Télécharger le fichier

First meeting of ITCC International Sponsors

First meeting of ITCC International Sponsors

The 5 ITCC International Sponsors who were selected by an independent scientific and ... | En savoir plus

Children without Cancer Run/Walk 2014

Children without Cancer Run/Walk 2014

Third edition of the Children without Cancer Run/Walk - Register now | En savoir plus

Children without Cancer Run/Walk

Children without Cancer Run/Walk

Second edition of the Children without Cancer Run/Walk - 400000 Euros for the ITCC ... | En savoir plus

ITCC Trial Registry

ITCC Trial Registry

ITCC is currently running 15 Trials 7 solid tumor 7 leukemia 1 supportive | En savoir plus

ITCC clinical trails

Children & Parents CORNER Learn More

The Innovative Therapies for Children with Cancer (ITCC) Consortium was created in 2003. It is a non profit organisation under the French Law. About ITCC …

 

ITCC gathers 43 European Paediatric Oncology Departments with expertise in conducting early phase trials in children and adolescents, and 9 European research laboratories.

The aim of this organisation is to develop novel therapies for the treatment of paediatric and adolescent cancers in cooperation with regulatory bodies, pharmaceutical enterprises, parents and patients.

 

In January 2011 ITCC was established as a European Category 1 Network for Paediatric Research at the European Medicines Agency (EnprEMA).

Its structure comprises several Committees which take care and contribute to a particular issue in the development of novel therapeutic strategies in paediatric oncology